West China Second University Hospital
Chengdu, Sichuan, 610041, China
NCT Number: NCT03185156
This is a randomized, placebo-controlled trail, the objective of this study is observation the effect of sub hypnotic dose of propofol for prevention of nausea and vomiting induced by hemabate during spinal anesthesia for elective cesarean section. The primary outcome is the presence of post-delivery intra-operative nausea and vomiting in parturients. The patients demographic characteristics, blood pressure, sensory block level, and the medications will be collected.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Phase 4
Chengdu, Sichuan, 610041, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
first dose 0.3mg/Kg propofol, then 1mg/Kg/hr micro-pump
first dose 0.03ml/Kg placebo saline, then 0.1ml/Kg/hr micro-pump
Time frame: 24 hours
the patients were not asked directly about nausea during the course of the surgery, but its incidence was recorded when spontaneously reported vomiting was recorded as observed by investigator
West China Second University Hospital
Other
The Preventive Effect of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07403370
Nausea, Nausea and Vomiting
Jinan, Shandong, China
View Trial DetailsNCT00343460
Nausea, Nausea and Vomiting
Anniston, Alabama, United States
View Trial DetailsNCT07145320
Breast Cancer, Breast Diseases
Ankara, Adnan Saygun, Turkey (Türkiye)
View Trial DetailsNCT02116530
Hematologic Diseases, Hematologic Neoplasms
Anchorage, Alaska, United States
View Trial Details